Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 203

The global single-use bioprocessing market is projected to be valued at USD 18.01 billion in 2025 and USD 33.67 billion by 2030, exhibiting a CAGR of 13.3% from 2025 to 2030. The market growth can be attributed to the growing adoption of single-use technologies among contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs), and reduced capital investments required for single-use systems compared to traditional stainless-steel systems. Additionally, the market has been significantly driven by increased productivity & reduced risk of cross-contamination. Traditional stainless-steel systems often require time-consuming cleaning and validation between batches, leading to significant downtime and resource allocation. In contrast, single-use systems offer a streamlined approach, eliminating the need for extensive cleaning procedures by employing disposable components. This feature enables manufacturers to accelerate product substitutions and process transitions, maximizing equipment utilization and overall production throughput.

“Upstream bioprocessing segment is projected to record the highest CAGR during the forecast period”

Based on workflow, the single-use bioprocessing market is segmented into upstream and downstream bioprocessing. In 2024, the upstream bioprocessing segment held the largest share of the single-use bioprocessing market. It involves a series of preparatory steps for fermenting cell lines, which can be executed through various methods, such as perfusion or fed-batch. This biotechnological process covers multiple stages, including the proper storage of microorganisms, cell isolation, and cultivation until the final harvest. Additionally, the segmental growth can be attributed to the escalating use of single-use bioprocessing for biopharmaceutical formulation.

“Pharmaceutical & biotechnology companies segment accounted for the largest share in 2024”

In 2024, the pharmaceutical & biotechnology companies segment accounted for the largest share by end user in the global single-use bioprocessing market. Single-use equipment decreases cross-product/batch contamination risks, increases product integrity, reduces downtime, lowers cleaning costs, decreases facility setup expenses, provides a smaller manufacturing footprint, and improves facility flexibility and adaptability. These advantages bolster the adoption of single-use bioprocessing products in pharmaceutical & biopharmaceutical companies. The widespread use of single-use bioprocessing equipment and consumables in established and developed markets, such as North America and Europe, has supported market growth.

“US dominated the North American single-use bioprocessing market in 2024”

The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for single-use bioprocessing products is expected to grow over the coming years, driven by the increasing focus on biopharmaceuticals and the need for safe & high-quality products in the healthcare industry. It has a highly advanced market in terms of R&D due to the improved healthcare infrastructure, strong government initiatives supporting biotechnology research and advanced manufacturing, and substantial private funding directed toward innovative bioprocessing technologies. This helps develop innovative and advanced technologies for research. Pharmaceutical companies are actively participating in the development of biologics and biosimilars and increasingly utilizing single-use bioprocessing, which offers less turnaround time, has low installation costs, and is energy-efficient. These factors support the growth of the single-use bioprocessing market across the country.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply-side - 70% and Demand-side - 30%
• By Designation: Managers - 45%, CXOs & Directors - 30%, and Executives - 25%
• By Region: North America - 40%, Europe - 25%, Asia Pacific - 25%, Latin America - 5%, and Middle East & Africa - 5%

Merck KGaA (Germany), Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Entegris (US), Getinge AB (Sweden), and Parker Hannifin Corporation (US) are some of the key players operating in the single-use bioprocessing market.

Research Coverage:

This research report categorizes the single-use bioprocessing market by product [equipment (single-use bioreactors, single-use mixing systems, single-use filtration systems, single-use chromatography systems, and other single-use equipment) and consumables (single-use bags and containers, single-use filters, single-use chromatography columns, single-use assemblies, single-use sensors, and other single-use consumables)]; application (cell culture, filtration, purification, mixing, storage & transfer, and other applications); workflow (upstream and downstream bioprocessing); molecule type (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies); end user (pharmaceutical & biotechnology companies, CMOs & CROs, and other end users); and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report’s scope covers detailed information regarding the leading factors, such as drivers, restraints, challenges, and opportunities, influencing the market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the single-use bioprocessing market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall single-use bioprocessing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers (Growing adoption among CDMOs & CMOs, increased productivity & reduced risk of cross contamination, reduced capital investment, environmental sustainability due to reduced water and energy consumption, growing biologics & biosimilars market), restraints (Issues related to leachables & extractables, regulatory compliance issues, and impact of PFAS restrictions on product development), opportunities (untapped market potential in emerging economies, customization options driving growth and innovation), and challenges (lack of standardization, waste disposal, and potential breakage of SU bags) influencing the growth of the market
• Product Development/Innovation: Detailed insights on newly launched products of the single-use bioprocessing market
• Market Development: Comprehensive information about lucrative markets–the report analyses the market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use bioprocessing market
• Competitive Assessment: Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Entegris (US), Getinge AB (Sweden), and Parker Hannifin Corporation (US), among others in the market

Show more